Risk Analysis of Heart Failure in Hypertensive Patients at the Emergency Department of Jember Clinic Hospital
DOI:
https://doi.org/10.69606/jps.v3i01.178Keywords:
Heart Failure, Hypertension, Framingham ScoreAbstract
Background: Hypertensive patients experience an increase in systemic blood pressure, which places additional strain on the heart. This condition can increase the risk of heart failure. Objective: To assess the risk of heart failure in hypertensive patients treated at the Emergency Department of Jember Klinik Hospital. Method: This study employed a descriptive design using a cross-sectional approach. The study population consists of hypertensive patients at the Emergency Department of Jember Klinik Hospital. A total of 57 hypertensive patients who underwent examination at the Emergency Department of Jember Klinik Hospital between April and June 2024. The criteria of respondents were patients aged 30 to 74 years, composmentis, and able to communicate. The research instrument used the Framingham score to assess heart failure risk. Analysis statistic used analysis descriptive. Results: This study show that 6 respondents (10.5%) have a low risk, 17 respondents (29.8%) have a moderate risk, and 34 respondents (59.7%) have a high risk. Conclusion: The findings indicate that the majority of respondents are in the high-risk category for heart failure. Some risk factors need to be considered, including age, sex, systolic pressure, hypertension therapy, smoking, diabetes, and IMT so that respondents are able to control these.
References
Anies. (2021). Penyakit Jantung & Pembuluh Darah. Ar-Ruzz Media.
Drazner, M. (2011). The progression of hypertensive heart disease. Circulation, 123, 327–334.
Duttagupta, S., Thachathodiyl, R., Rameshan, A., Venkatachalam, A., Georgy, S., & Menon, J. (2022). Effectiveness of Framingham and ASCVD Risk Scores in Predicting Coronary Artery Disease-A Comparative Study with Syntax Score. J Assoc Physicians India, 69(12), 11–12.
Garcia, J., Wanjalla, C., Mashayekhi, M., & Hasty, A. (2022). Immune cell activation in obesity and cardiovascular disease. Curr Hypertens Rep, 24, 627–637.
Hamo, C., Kwak, L., Wang, D., Florido, R., Echouffo-Tcheugui, J., Blumenthal, R., Loehr, L., Matsushita, K., Nambi, V., Ballantyne, C., Selvin, E., Folsom, A., Heiss, G., Coresh, J., & Ndumele, C. (2022). Heart Failure Risk Associated with Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. J Am Heart Assoc, 11(4), e021583.
Hermida, R., Ayala, D., Mojón, A., Smolensky, M., Crespo, J., Otero, A., Domínguez-Sardiña, M., Moyá, A., Ríos, M., Castiñeira, M., Callejas, P., Pousa, L., Sineiro, E., Salgado, J., Durán, C., Sánchez, J., & Fernández, J. (2021). Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure. Rev Esp Cardiol, 74(11), 953–961.
Kementerian Kesehatan RI. (2018). Riset Kesehatan Dasar.
Lawson, C., Zaccardi, F., Squire, I., Okhai, H., Davies, M., Huang, W., & et, al. (2020). Risk factors for heart failure. Circ Heart Fail, 13(e006472).
Lidgard, B., Zelnick, L. R., Go, A., O’Brien, K. D., & Bansal, N. (2022). Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction. Journal of the American Heart Association, 11(7).
Masenga, S. K., & Kirabo, A. (2023). Hypertensive heart disease: risk factors, complications and mechanisms. Frontiers in Cardiovascular Medicine, 10:1205475.
Messerli, F., Rimoldi, S., & Bangalore, S. (2017). The transition from hypertension to heart failure: contemporary update. JACC Heart Fail, 5, 543–551.
Pranata, A. E., & Prabowo, E. (2017). Keperawatan Medikal Bedah Dengan Gangguan Sistem Kardiovaskuler. Nuha Medika.
Rodriguez, C., Swett, K., Agarwal, S., Folsom, A., Fox, E., Loehr, L., Ni, H., Rosamond, W., & Chang PP. (2014). Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study. JAMA Intern Med, 174, 1252–1261.
Sartik, S., Tjekyan, RM. S., & Zulkarnain, M. (2017). Risk Factors and The Incidence of Hypertension In Palembang. Jurnal Ilmu Kesehatan Masyarakat, 8(3), 180–191.
Wang, J.-G. (2021). One more step toward an Asian hypertension guideline. J Clin Hypertens, 23, 401–402.
Zhou, B., Carrillo-Larco, R., Danaei, G., Riley, L., Paciorek, C., Stevens, G., & et, al. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 398, 957–980.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Roby Aji Permana
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
